Works about POLY ADP ribose
Results: 929
Clinical Impact of Olaparib for Platinum-Sensitive Recurrent Ovarian Cancer.
- Published in:
- Diseases, 2025, v. 13, n. 2, p. 51, doi. 10.3390/diseases13020051
- By:
- Publication type:
- Article
Solid‐Phase Synthesis and Biological Evaluation of Peptides ADP‐Ribosylated at Histidine.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 4, p. 1, doi. 10.1002/ange.202313317
- By:
- Publication type:
- Article
Profiling of the ADP‐Ribosylome in Living Cells.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 18, p. 1, doi. 10.1002/ange.202200977
- By:
- Publication type:
- Article
Icariin alleviates hypoxia‐induced damage in MC3T3‐E1 cells by downregulating TALNEC2.
- Published in:
- Biotechnology & Applied Biochemistry, 2020, v. 67, n. 6, p. 1000, doi. 10.1002/bab.1874
- By:
- Publication type:
- Article
Nanoparticles-SIRT1 Prevents Endothelial Progenitor Cells Senescence by Modulating Nitric Oxide Expression and Reducing Poly ADP-ribose Polymerase: In vitro Study.
- Published in:
- Trends in Sciences, 2024, v. 21, n. 6, p. 1, doi. 10.48048/tis.2024.7519
- By:
- Publication type:
- Article
Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3/miR-181-5p/GATA6 pathway.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16314
- By:
- Publication type:
- Article
1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1968, doi. 10.1080/14756366.2021.1972993
- By:
- Publication type:
- Article
Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1).
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 1606, doi. 10.1080/14756366.2020.1804382
- By:
- Publication type:
- Article
Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials.
- Published in:
- Journal of Market Access & Health Policy, 2022, v. 10, n. 1, p. 1, doi. 10.1080/20016689.2022.2078474
- By:
- Publication type:
- Article
A Novel Combination of Ruthenium Polypyridyl Complex, [Ru(dppz)2PiP]<sup>2+</sup> and PARP Inhibitor, NU1025 for Cancer Treatment.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2019, v. 15, p. 26
- By:
- Publication type:
- Article
Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-78442-y
- By:
- Publication type:
- Article
Author Correction: Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Defektif Homolog Rekombinasyon DNA Tamiri ve PARP İnhibisyonu Arasındaki Sentetik Letal Etkileşim.
- Published in:
- Journal of the Institute of Science & Technology / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2022, v. 12, n. 4, p. 2459, doi. 10.21597/jist.1095366
- By:
- Publication type:
- Article
Neuroprotective Effects of Activated Protein C Involve the PARP/AIF Pathway against Oxygen-Glucose Deprivation in SH-SY5Y Cells.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 12, p. 959, doi. 10.3390/brainsci10120959
- By:
- Publication type:
- Article
Avenanthramide C Prevents Neuronal Apoptosis via PI3K/Akt/GSK3β Signaling Pathway Following Middle Cerebral Artery Occlusion.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 11, p. 878, doi. 10.3390/brainsci10110878
- By:
- Publication type:
- Article
Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 10, p. 1269, doi. 10.3390/biom14101269
- By:
- Publication type:
- Article
Combination Treatment Strategies to Overcome PARP Inhibitor Resistance.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1480, doi. 10.3390/biom13101480
- By:
- Publication type:
- Article
The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 8, p. 1195, doi. 10.3390/biom13081195
- By:
- Publication type:
- Article
PCNA Ubiquitylation: Instructive or Permissive to DNA Damage Tolerance Pathways?
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 10, p. 1543, doi. 10.3390/biom11101543
- By:
- Publication type:
- Article
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 8, p. 1188, doi. 10.3390/biom11081188
- By:
- Publication type:
- Article
The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 5, p. 722, doi. 10.3390/biom11050722
- By:
- Publication type:
- Article
Differential Expression of ADP/ATP Carriers as a Biomarker of Metabolic Remodeling and Survival in Kidney Cancers.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 1, p. 38, doi. 10.3390/biom11010038
- By:
- Publication type:
- Article
Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 9, p. 1325, doi. 10.3390/biom10091325
- By:
- Publication type:
- Article
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 5, p. 687, doi. 10.3390/biom10050687
- By:
- Publication type:
- Article
The Role of Nicotinamide in Cancer Chemoprevention and Therapy.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 3, p. 477, doi. 10.3390/biom10030477
- By:
- Publication type:
- Article
Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 2, p. 297, doi. 10.3390/biom10020297
- By:
- Publication type:
- Article
[Pt(O,O′-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 3, p. 92, doi. 10.3390/biom9030092
- By:
- Publication type:
- Article
Cucurbitacin D Overcomes Gefitinib Resistance by Blocking EGF Binding to EGFR and Inducing Cell Death in NSCLCs.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00062
- By:
- Publication type:
- Article
PARP Inhibitors in Prostate and Urothelial Cancers.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00114
- By:
- Publication type:
- Article
Streptavidin-Conjugated DNA for the Boronate Affinity-Based Detection of Poly(ADP-Ribose) Polymerase-1 with Improved Sensitivity.
- Published in:
- Biosensors (2079-6374), 2023, v. 13, n. 7, p. 723, doi. 10.3390/bios13070723
- By:
- Publication type:
- Article
Ethanol extracts of Hizikia fusiforme induce apoptosis in human prostate cancer PC3 cells via modulating a ROS-dependent pathway.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2020, v. 10, n. 2, p. 78, doi. 10.4103/2221-1691.275422
- By:
- Publication type:
- Article
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 11, p. 1201, doi. 10.1007/s40273-020-00949-9
- By:
- Publication type:
- Article
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
- Published in:
- 2019
- By:
- Publication type:
- Letter
Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy.
- Published in:
- Journal of Molecular Recognition, 2021, v. 34, n. 7, p. 1, doi. 10.1002/jmr.2891
- By:
- Publication type:
- Article
Lentinan inhibits melanoma development by regulating the AKT/Nur77/Bcl-2 signaling axis.
- Published in:
- Journal of Cancer, 2025, v. 16, n. 2, p. 543, doi. 10.7150/jca.100863
- By:
- Publication type:
- Article
The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review.
- Published in:
- Cell & Bioscience, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13578-020-00390-7
- By:
- Publication type:
- Article
Use of PARP inhibitors in prostate cancer: from specific to broader application.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1164067
- By:
- Publication type:
- Article
Dendrimer-modified gelatin methacrylate hydrogels carrying adipose-derived stromal/stem cells promote cartilage regeneration.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02705-6
- By:
- Publication type:
- Article
Restoration of NAD<sup>+</sup> homeostasis protects C2C12 myoblasts and mouse levator ani muscle from mechanical stress-induced damage.
- Published in:
- Animal Cells & Systems, 2022, v. 26, n. 4, p. 192, doi. 10.1080/19768354.2022.2106303
- By:
- Publication type:
- Article
Honokiol ameliorates oxidative stress-induced DNA damage and apoptosis of c2c12 myoblasts by ROS generation and mitochondrial pathway.
- Published in:
- Animal Cells & Systems, 2020, v. 24, n. 1, p. 60, doi. 10.1080/19768354.2019.1706634
- By:
- Publication type:
- Article
RNA visualization and single-cell transcriptomics: methods and applications.
- Published in:
- Transcription (2154-1264), 2023, v. 14, n. 3-5, p. 89, doi. 10.1080/21541264.2023.2286761
- By:
- Publication type:
- Article
A method for in situ visualization of Protein-Nascent RNA interactions in single cell using Proximity Ligation Assay (IPNR-PLA) in mammalian cells.
- Published in:
- Transcription (2154-1264), 2023, v. 14, n. 3-5, p. 146, doi. 10.1080/21541264.2023.2190296
- By:
- Publication type:
- Article
A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer.
- Published in:
- Application of Clinical Genetics, 2021, v. 14, p. 255, doi. 10.2147/TACG.S261737
- By:
- Publication type:
- Article
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line.
- Published in:
- International Journal of Endocrinology, 2015, v. 2015, p. 1, doi. 10.1155/2015/978371
- By:
- Publication type:
- Article
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02139-7
- By:
- Publication type:
- Article
PARP inhibitors in gastric cancer: beacon of hope.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02005-6
- By:
- Publication type:
- Article
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01930-w
- By:
- Publication type:
- Article
Genes de predisposición al cáncer de mama.
- Published in:
- Salud Uninorte, 2018, v. 34, n. 3, p. 766
- By:
- Publication type:
- Article
Classification of Burn Depth.
- Published in:
- ePlasty: Open Access Journal of Plastic Surgery, 2024, p. 1
- By:
- Publication type:
- Article
The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection.
- Published in:
- Journal of Infection in Developing Countries, 2022, v. 16, n. 1, p. 101, doi. 10.3855/jidc.15386
- By:
- Publication type:
- Article